logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Entrectinib/larotrectinib/selitrectinibAcquired drug resistance: 3 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2019年 / 1780卷 / 1期
关键词:
D O I:
10.1007/s40278-019-71640-6
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:149 / 149
相关论文
共 50 条
  • [31] AntineoplasticsAcquired drug resistance: 6 case reports
    Reactions Weekly, 2019, 1778 (1) : 51 - 51
  • [32] AntiviralsDevelopment of drug resistance: 4 case reports
    Reactions Weekly, 2022, 1906 (1) : 80 - 80
  • [33] AntiretroviralsDevelopment of drug resistance: 6 case reports
    Reactions Weekly, 2020, 1811 (1) : 49 - 49
  • [34] LevofloxacinAcquired drug resistance: 2 case reports
    Reactions Weekly, 2022, 1915 (1) : 252 - 252
  • [35] MoxifloxacinAcquired drug resistance: 5 case reports
    Reactions Weekly, 2022, 1912 (1) : 302 - 302
  • [36] AntineoplasticsDevelopment of drug resistance: 2 case reports
    Reactions Weekly, 2022, 1922 (1) : 69 - 69
  • [37] LinezolidEmergence of drug resistance: 2 case reports
    Reactions Weekly, 2021, 1869 (1) : 209 - 209
  • [38] DolutegravirAcquired drug resistance: 4 case reports
    Reactions Weekly, 2022, 1901 (1) : 215 - 215
  • [39] AntitubercularsAcquired drug resistance: 9 case reports
    Reactions Weekly, 2015, 1579 (1) : 56 - 56
  • [40] AntineoplasticsAcquired drug resistance: 44 case reports
    Reactions Weekly, 2023, 1966 (1) : 45 - 45
← 12345 →